ABSTRACT Measurement of serum theophylline concentration is usually recommended before intravenous aminophylline is given to patients taking oral theophylline. Fifty patients with worsening airflow obstruction, all of whom were taking oral theophyllines and who had no contraindication to the use of parenteral aminophylline, were randomly allocated into two groups before treatment was given. The dose of aminophylline was calculated without (group A) and with (group B) knowledge of admission serum theophylline concentration. In group A a regimen incorporating corrections to account for factors affecting theophylline clearance was used in an attempt to represent a "knowledgeable" approach; in group B a formula incorporating the known serum theophylline concentration at the time of admission was used. All loading doses were given over 30 minutes as "mini infusions." The two groups were well matched for age, blood gas tensions, and severity of airflow obstruction. The results for four patients (one from group A and three from group B) were excluded from analysis after completion of the study. In each group the mean admission serum theophylline concentration measured (group A: 8-4 (SD 6.0) mg/I; group B: 7-2 (5 7) mg/1) and the aminophylline doses used (group A: loading bolus 172 (45-5) mg, infusion 815 (198) mg; group B: loading bolus 233 (189) mg, infusion 788 (214) mg) wcre similar. Mean serum theophylline concentrations during 24 hours' aminophylline treatment, number of patients with a serum theophylline concentration greater than 20 mg/l, symptoms of toxicity, and outcome were also similar in the two groups. Although satisfactory use of parenteral aminophylline was achieved for most patients without knowledge of serum theophylline concentration at the time of admission to hospital (with the aid of a "knowledgeable" clinical approach and constant infusion pumps), prompt measurement of serum theophylline concentration at the time of admission identified patients with either suboptimal or potentially hazardous theophylline concentrations.
Accepted 15 April 1986 airflow obstruction are taking oral theophyllines and estimates of appropriate intravenous aminophylline dosage in such cases have been found to be imprecise.' 7 It is therefore recommended that serum theophylline concentrations should be measured before and during the use of parenteral aminophylline.8'-Facilities for measurements are not, however, always available and, even when they are, doctors may wish to start treatment immediately, resorting to "blind" treatment with a low loading dose of aminophylline (for example, 2 5-3 Omg/kg). 11 12 In a recent study of the use of parenteral aminophylline in a district general hospital7 we found that 760 clinicians vary in their practice and were often unaware of interpatient variability and other factors affecting theophylline clearance. We recommended regular monitoring of concentrations, and a more "knowledgeable" clinical approach to the use of intravenous aminophylline in patients taking oral theophyllines.
The purpose of this prospective study was to determine the value of prompt measurement of the serum theophylline concentrations of patients receiving oral theophylline on their admission to hospital with worsening airflow obstruction. Two schemes for parenteral aminophylline dosage were compared: in one the doses were calculated from a formula with knowledge of serum theophylline concentration at admission; in the other scheme, representing a "knowledgeable" clinical approach, doses were based on a standard regimen that was adjusted to account for factors known to affect theophylline clearance.
Methods

PATIENTS
Fifty adult patients (23 of them women), mean age 59 3 (14 7) years, who had been prescribed (and informed us that they were taking) regular slow release theophylline drugs prior to admission, were entered into the study. Patients known to have liver disease or allergy to theophyllines, and those receiving drugs known to affect theophylline clearance, were excluded. All 
Results
Of the 50 patients studied, four were excluded from consideration in the results. One patient was withdrawn from group A because treatment with erythromycin was started during the aminophylline infusion. Three were withdrawn from group B, two because oral theophylline was inadvertently continued during the aminophylline infusion and a third because wheezing was found to be due to a bronchial carcinoma.
All patients in group A, 13 of whom were smokers, had asthma. Eight patients (all men) in group B, three of whom were smokers, had worsening airflow obstructon related to chronic bronchitis and emphysema. The remainder in group B (14 patients, 9 of them smokers) had asthma.
There was no significant difference between the two groups with respect to either age, body weight (actual or ideal), or arterial blood gas tensions (table 2) .
SERUM THEOPHYLLINE CONCENTRATIONS ON ADMISSION
Both groups had a wide range of serum theophylline Table 2 Age, body weight, and arterial blood gas tensions ofpatients admitted to the study ( 
Pao2-arterial oxygen tension: Paco -arterial carbon dioxide tension. The treatment regimens used in this study were such that aminophylline loading doses were given to all patients who were randomised into group A. It has been suggested that this approach is potentially hazardous.6 Boluses were given to only seven patients whose admission serum theophylline concentration was greater than 10 mg/l and a potentially dangerous serum concentration (323 mg/l at 1 hour: fig2) was recorded in only one patient; parenteral aminophylline was used at a time when this patient's condition was critical because of pneumonia and severe hypoxaemia; the safe, effective use of parenteral aminophylline in these circumstances is extremely difficult. The highest serum theophylline concentration at one hour in the six other patients was 24 5 mg/l and no symptom suggesting theophylline toxicity was recorded in any of these patients. In comparison two patients in group B, who were not given loading boluses because their serum theophylline concentrations on admission were 16 3 and 18 1 mg/l respectively, also reached a concentration greater than 20 mg/l at 1 hour. This reflects either changes in theophylline clearance or perhaps the fact that oral theophylline had been taken shortly before admission, so that the concentration on admission did not represent a steady state result.
The use of a loading bolus without knowledge of serum theophylline concentrations did not cause problems in this study, but the average dose given was only 170 mg, less than the 250 mg observed in our previous study7 and by others." The loading doses used were derived from the patient's ideal rather than actual body weight. Actual weight was suggested by Gal"4 on the basis of a pharmacokinetic study in normal subjects not taking oral theophyllines. This was clearly inappropriate for our study-for example, a woman with asthma whose actual body weight was 114 kg and whose serum theophylline concentration on admission was 84 mg/I would have been given over 400mg of aminophylline if her actual body weight had been used rather than her ideal weight, which resulted in a dose of 200mg; this raised the serum concentration at I hour to 14-4 mg/i. A factor contributing to the safety of the bolus doses used in both groups of patients in this study was the mode of administration. The doses were given over half an hour as "mini infusions" by constant infusion pumps. This method was chosen because theophylline has two compartment kinetics, in which the bronchodilating effect correlates with the second (or tissue) compartment rather than the initial "volume of distribution" compartment15; thus rapid administration may cause very high theophylline concentrations because a finite time is needed for the drug to be distributed from the central to the tissue compartment.4
It is generally recommended that loading aminophylline doses are given over 10-15 minutes,16 but our study suggests that this may be too short a time.
A clear problem with the use of loading boluses calculated without knowledge of serum theophylline -763 0 764 concentration was the undertreatment of patients whose concentration on admission was low. The study design presupposed that group A patients had appreciable theophylline in their blood at the time of hospital admission and individuals who did not were subsequently undertreated. Nevertheless, all such patients in group A had a serum concentration greater than 5 mg/l at one hour, which, although not ideal, is associated with a degree of bronchodilatation.'7 By comparison, three of seven patients in group B whose serum theophylline concentration on admission was less than 25 mg/l also failed to reach a serum concentration within the therapeutic range at 1 hour; thus, even with knowledge of admission serum theophylline concentration, an ideal loading dose cannot be guaranteed for every patient. The target serum theophylline concentration of 15 mg/l was chosen because it is in the middle of the therapeutic range and allows a safe margin below the potentially toxic range. Choosing a higher value may have improved the serum theophylline concentration at 1 hour in group B, but in view of interpatient variability in theophylline clearance'8 this would have been at the expense of risking toxicity in some patients.
The average total infusion doses given to the patients in the two groups were similar to those previously recommended (180 mg six hourly in an adult weighing 60kg)'9 and considerably less than those used when clinicians choose doses by guess work (I 175 (SD 268) mg in 24 hours).7 Although individual results were more variable in group A, most patients in the study had serum theophylline concentrations greater than 10 mg/l throughout their aminophylline infusions. Furthermore, results for individual patients were relatively constant throughout the infusion. This is in contrast with the results of our previous study,7 which showed that patients are inadequately treated when the doses of infused aminophylline are guessed. In the present study the patients in both groups whose serum theophylline concentrations were lowest during infusions were those whose serum concentration at 1 hour was suboptimal, emphasising the value of using an accurate loading bolus.
Three patients (all critically ill, two in group A and one in group B) were "overtreated" (serum theophylline concentration greater than 25 mg/l on at least one occasion) during their aminophylline infusions, The general lack of symptoms of theophylline toxicity in both groups was unexpected and gratifying. No patient complained of either headache or heartburn during the study and only two patients suffered from nausea and vomiting. The lack of symptoms is probably due to the use of constant rate pumps to administer both loading doses ("mini infusions") and maintenance treatment and to setting the "target" theophylline concentration at 15 mg/I, which meant that the theophylline concentration was maintained within the range 5-20 mg/l in most patients.
Is it possible, in clinical practice, to obtain better serum theophylline concentrations than those seen in the patients in this study, the circumstances of which may not be typical of practice in some district general hospitals? Results might have been improved if two factors could have been overcome. Firstly, understatement by some patients about their smoking habits may have resulted in administration of suboptimal aminophylline doses. Heavy smokers may need three months of abstinence from cigarettes before their theophylline clearance becomes that of a nonsmoker20 and the doses of aminophylline used in such patients should be adjusted appropriately. The second and perhaps most difficult problem to contend with was the relationship between the time when the last oral dose of theophylline had been taken and measurement of serum theophylline concentration. Neither treatment regimen used in this study can take this fully into account. It has been suggested that consistent serum theophylline concentrations can be obtained by using drug doses derived from calculations of clearance rates based on two measurements made during aminophylline infusion. 2' 22 Although these methods are claimed to be simple, they are probably impractical for routine clinical practice.
In conclusion, the results of this study suggest that the doses of intravenous aminophylline used in routine clinical practice may be excessive. Measurement of serum theophylline concentration at the time of admission to hospital identified patients whose compliance with oral theophylline treatment was poor or whose maintenance dose was suboptimal, and avoided the administration of loading doses to patients whose admission serum theophylline concentration was potentially toxic. Similar benefit might be obtained, however, by regular non-urgent outpatient monitoring of serum theophylline concentration and, furthermore, knowledge of serum theophylline concentration at the time of admission to hospital does not guarantee optimal parenteral aminophylline treatment. Many patients may be given satisfactory parenteral aminophylline treatment without knowl-
